Xact OMXC25 ESG UCITS ETF (CPH:XACTC25)
Denmark · Delayed Price · Currency is DKK 188.56
+2.50 (1.34%)
Apr 1, 2026, 4:52 PM CET
6.14% (1Y)
| Assets | 5.34B |
| Expense Ratio | 0.20% |
| PE Ratio | 17.11 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +6.14% |
| Volume | 79,723 |
| Open | 190.38 |
| Previous Close | 186.06 |
| Day's Range | 187.64 - 191.70 |
| 52-Week Low | 147.96 |
| 52-Week High | 212.00 |
| Beta | 0.68 |
| Holdings | 31 |
| Inception Date | Feb 4, 2019 |
About XACTC25
The fund is an exchange-traded index fund and its objective is to follow the performance of the OMX Copenhagen 25 Index as closely as possible. The funds base currency is DKK.
Asset Class Equity
Category Large Cap
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol XACTC25
Provider XACT
Index Tracked OMX Copenhagen 25 GI Index - DKK
Performance
XACTC25 had a total return of 6.14% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.09%.
Top 10 Holdings
76.25% of assets| Name | Symbol | Weight |
|---|---|---|
| DSV A/S | DSV | 16.11% |
| Novo Nordisk A/S | NOVO.B | 12.12% |
| Danske Bank A/S | DANSKE | 11.37% |
| Vestas Wind Systems A/S | VWS | 9.18% |
| Novozymes A/S | NSIS.B | 7.13% |
| Genmab A/S | GMAB | 6.18% |
| Coloplast A/S | COLO.B | 4.12% |
| Ørsted A/S | ORSTED | 4.03% |
| A.P. Møller - Mærsk A/S | MAERSK.B | 3.02% |
| A P Moller Maersk AS Class A | MAERSKA.CO | 2.99% |